Claragene is the first patented absorbable and stable NAD+ product to hit the market. NAD+ helps to reduce withdraw symptoms from addictive substances, restore neurotransmitters, and reduce anxiety, stress, post-traumatic stress, and other conditions by returning the brain to proper functioning. In 1983 a bioavailability study indicated that ingested NAD+ was primarily hydrolyzed in the small intestine by brush border cells (Baum et al., 1982; Gross and Henderson, 1983), which means when NAD+ is ingested it is reduced to NADH changing it into a completely different molecule before entering the bloodstream and no longer rendering it effective as NAD+. Our product is a sublingual lozenge that allows the NAD+ molecule to be absorbed quickly into the bloodstream through the buccal gland without being reduced. Now you can experience the benefits of NAD therapy without having to use IV treatment.